Literature DB >> 6120875

Absence of islet alpha cell function in pancreatectomized patients.

A Tiengo, M Bessioud, I Valverde, A Tabbi-Anneni, S Delprato, J Alexandre, R Assan.   

Abstract

Plasma immunoreactive glucagon, C-peptide and substrates (glucose, lactate, and alanine) were measured in 21 pancreatectomized patients and 28 patients with chronic calcifying pancreatitis during arginine infusion. Results were compared with those obtained in control and in insulin-dependent diabetic subjects, and in pancreatectomized subjects receiving a combined infusion of glucagon and arginine or somatostatin and arginine. Plasma immunoreactive glucagon in the pancreatectomized patients was 230 +/- 26 pg/ml (control subjects 100 +/- 13 pg/ml, p less than 0.001), but was unchanged following arginine or somatostatin. Following ethanol extraction of plasma it became undetectable. Similar results were obtained in patients with chronic pancreatitis. In contrast to the insulin-dependent diabetic subjects, no changes in blood glucose, lactate, and alanine concentrations were found during arginine infusion in the pancreatectomized or pancreatitis patients. Addition of glucagon restored the metabolic response to arginine in the pancreatectomized patients. Our results confirm previous smaller studies that in pancreatectomized patients, A cell function is absent or insignificant.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6120875     DOI: 10.1007/bf00253865

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  36 in total

1.  High molecular weight glucagon-like immunoreactivity in plasma.

Authors:  G C Weir; S D Knowlton; D B Martin
Journal:  J Clin Endocrinol Metab       Date:  1975-02       Impact factor: 5.958

2.  [Comparison of glucagon secretions in diabetes mellitus with or without acquired organic pancreatopathy].

Authors:  R Assan; A Tiengo
Journal:  Pathol Biol (Paris)       Date:  1973-01

3.  Plasma glucose, insulin, pancreatic, and enteroglucagon levels in normal and depancreatized dogs.

Authors:  T Matsuyama; P P Foà
Journal:  Proc Soc Exp Biol Med       Date:  1974-10

4.  Increased "glucagon immunoreactivity" in plasma of totally depancreatized dogs.

Authors:  M Vranic; S Pek; R Kawamori
Journal:  Diabetes       Date:  1974-11       Impact factor: 9.461

5.  Molecular size of extractable glucagon and glucagon-like immunoreactivity (GLI) in plasma.

Authors:  I Valverde; D Rigopoulou; J Marco; G R Faloona; R H Unger
Journal:  Diabetes       Date:  1970-09       Impact factor: 9.461

6.  [Indications and results of total pancreatectomy in the treatment of acute necrotizing pancreatitis].

Authors:  J H Alexandre; J P Camilleri; R Assan; M T Guerrieri; A Bonan
Journal:  Chirurgie       Date:  1977

7.  Glucagon secretion in acute and chronic pancreatitis.

Authors:  M Donowitz; R Hendler; H M Spiro; H J Binder; P Felig
Journal:  Ann Intern Med       Date:  1975-12       Impact factor: 25.391

8.  Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.

Authors:  R S Sherwin; M Fisher; R Hendler; P Felig
Journal:  N Engl J Med       Date:  1976-02-26       Impact factor: 91.245

9.  Extrapancreatic glucagon and glucagonlike immunoreactivity in depancreatized dogs. A quantitative assessment of secretion rates and anatomical delineation of sources.

Authors:  W A Muller; L Girardier; J Seydoux; M Berger; A E Renold; M Vranic
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

10.  Ketoacidosis in pancreatectomized man.

Authors:  A J Barnes; S R Bloom; K Goerge; G M Alberti; P Smythe; F P Alford; D J Chisholm
Journal:  N Engl J Med       Date:  1977-06-02       Impact factor: 91.245

View more
  10 in total

1.  Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy.

Authors:  S Del Prato; S Vigili de Kreutzenberg; R Trevisan; E Duner; A Avogaro; R Nosadini; U Baccaglini; C Tremolada; A Tiengo
Journal:  Diabetologia       Date:  1985-05       Impact factor: 10.122

2.  How does glucose regulate the human pancreatic A cell in vivo?

Authors:  C M Asplin; P M Hollander; J P Palmer
Journal:  Diabetologia       Date:  1984-03       Impact factor: 10.122

3.  Diabetogenic role of insulin's counterregulatory hormones in the isletectomized, diabetic goby.

Authors:  J T Haigwood; R M Flores; R Mazloumi; G Ngan; K M Kelley
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

4.  Pancreatic glucagon secretion and exocrine function (BT-PABA test) in chronic pancreatitis.

Authors:  U Keller; E Szöllösy; L Varga; K Gyr
Journal:  Dig Dis Sci       Date:  1984-09       Impact factor: 3.199

5.  Circulating glucagon after total pancreatectomy in man.

Authors:  J J Holst; J H Pedersen; F Baldissera; F Stadil
Journal:  Diabetologia       Date:  1983-11       Impact factor: 10.122

6.  Hyperglucagonemia and insulin-mediated glucose metabolism.

Authors:  S Del Prato; P Castellino; D C Simonson; R A DeFronzo
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

7.  Insulin receptors on circulating blood cells from patients with pancreatogenic diabetes: a comparison with type I diabetes and normal subjects.

Authors:  M Muggeo; P Moghetti; P P Faronato; A Valerio; A Tiengo; S Del Prato; R Nosadini
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

8.  Study of A- and B-cell function in beta-thalassemia major.

Authors:  M Maioli; A Pacifico; T Frulio; M Longinotti
Journal:  Acta Diabetol Lat       Date:  1983 Apr-Jun

9.  Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy.

Authors:  S Del Prato; A Tiengo; U Baccaglini; C Tremolada; E Duner; M C Marescotti; A Avogaro; I Valverde; R Nosadini; R Assan
Journal:  Diabetologia       Date:  1983-09       Impact factor: 10.122

10.  Characterization of diabetes following pancreatic surgery in patients with congenital hyperinsulinism.

Authors:  Alena Welters; Thomas Meissner; Jürgen Grulich-Henn; Elke Fröhlich-Reiterer; Katharina Warncke; Klaus Mohnike; Oliver Blankenstein; Ulrike Menzel; Nicolin Datz; Esther Bollow; Reinhard W Holl
Journal:  Orphanet J Rare Dis       Date:  2018-12-22       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.